Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manganese and Radiotherapy for Metastatic Solid Tumors or Lymphoma
NCT04873440Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of manganese chloride in solid tumor, lymphoma, sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
manganese chloride
03
Conditions
solid tumorlymphoma
Beyond the preview
Go deeper on NCT04873440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04873440.